Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Naftifine HCl and the Next Frontier in Antifungal Researc...
2025-10-19
This thought-leadership article explores how Naftifine HCl, a potent allylamine antifungal agent, is redefining antifungal research by targeting squalene 2,3-epoxidase to disrupt fungal cell membrane synthesis. Blending mechanistic insight with strategic guidance, we contextualize Naftifine HCl's value for translational researchers, integrate recent advances in cell signaling and differentiation, and chart a visionary course for bridging bench innovation with clinical solutions.
-
Naftifine HCl: Applied Antifungal Research & Experimental...
2025-10-18
Naftifine HCl empowers antifungal research with its robust squalene 2,3-epoxidase inhibition, enabling precise studies of fungal membrane disruption. This article delivers detailed protocols, troubleshooting strategies, and advanced applications, establishing Naftifine HCl as a cornerstone for translational mycology and sterol biosynthesis research.
-
RSL3: A Premier GPX4 Inhibitor for Ferroptosis Induction
2025-10-17
RSL3, a potent GPX4 inhibitor, is redefining ferroptosis-based cancer research by enabling precise modulation of oxidative stress and synthetic lethality in oncogenic RAS-driven models. This article guides researchers through best practices, advanced applications, and troubleshooting strategies to maximize experimental success with RSL3 in dissecting iron-dependent cell death pathways.
-
N6-Methyl-dATP: A Mechanistic and Strategic Breakthrough ...
2025-10-16
This thought-leadership article explores the transformative role of N6-Methyl-dATP, a methylated deoxyadenosine triphosphate analog, in advancing DNA replication fidelity studies, epigenetic pathway mapping, and translational oncology. By integrating mechanistic insights, recent leukemia epigenetics research, and strategic guidance for translational scientists, the article demonstrates why N6-Methyl-dATP is a critical tool for unlocking new frontiers in genomic medicine.
-
In conclusion we have demonstrated that diaryl pyrazolo pyri
2023-07-06

In conclusion, we have demonstrated that ,-diaryl-1-pyrazolo[3,4-]pyrimidine-3,6-diamines represent a novel class of ACK1 inhibitors. The presence of a polar substituent at C-4 of the N-6 aryl ring was shown to be unnecessary for maintaining high levels of inhibitory activity. Furthermore, selectivi
-
In conclusions MPE effects in causing lesser
2023-07-05

In conclusions, MPE effects in causing lesser increase in vaginal fluid pH could partly restore the vaginal acidity in sex-steroid deficient state. MPE could exert its effect via enhancing both H+ generation as well as H+extrusion into the vaginal lumen. Although gallic Triacetyl Resveratrol is the
-
Second the choice of the PAABD
2023-07-05

Second, the choice of the PAABD is critical for an efficient and sensitive biosensor. The sequence of the PAABD should present high affinity and efficient recognition of the phosphorylated substrate, as opposed to poor affinity for the unphosphorylated substrate, and should display a fully reversibl
-
L-Stepholidine sale The electrokinetic remediation technique
2023-07-05

The electrokinetic remediation technique is carried out with a low-level direct current, and the pollutants in soil can be transported and removed by the electric field [19]. This works well even in soil with low permeability via electro-osmotic flow and electro-migration [20]. The electrokinetic pr
-
Expression of Twist and the AR
2023-07-05

Expression of Twist1 and the AR are increased by oxidative stress, but the change in the receptor (mRNA/protein) is lost after treatment with siRNAs that target Twist 1 (Shiota et al., 2010). Twist 1 was found to bind to E-boxes, 5′-CANNTG-3′, in the proximal promoter (−442 to +51 bp) and upstream r
-
Data used in preparation of this article were
2023-07-05

Data used in preparation of this article were obtained from the ADNI database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing o
-
br Discussion AhR is a receptor that binds to a
2023-07-05

Discussion AhR is a receptor that binds to a great variety of lipophilic compounds, in particular those containing at least one aromatic ring (Abel and Haarmann-Stemmann, 2010, Guyot et al., 2013, Hahn, 2002). The main known function of this receptor is to induce the metabolism of these compounds
-
br AhR Modulators It is now well recognized
2023-07-05

AhR Modulators It is now well recognized that ligand-activated AhR induces an immune tolerance response by acting directly on the antigen-presenting DCs and indirectly by increasing the population of immunosuppressive Tregs 24, 95, 96. In addition to inhibiting the formation or depleting the AhR
-
bromodomain inhibitor Nrf br AhR br Nrf and AhR friends or f
2023-07-05

Nrf2 AhR Nrf2 and AhR: friends or foes for energetic metabolism? Perspectives in carcinogenesis upon xenobiotic exposure Acknowledgements Introduction Integration of endogenous and exogenous signals via appropriate receptors is at the core of biological differentiation and adaptive r
-
hydroxydopamine OHDA is a selective catecholaminergic neurot
2023-07-05

6-hydroxydopamine (6-OHDA) is a selective catecholaminergic neurotoxin mainly used to generate lesions in the nigrostriatal pathway in rats (Ungerstedt, 1968). The most common use of 6-OHDA is via unilateral injection into the rat medial forebrain bundle (MFB). DA depletion, nigral DA cell loss, and
-
NLX a k a F or
2023-07-05

NLX-112 (a.k.a. F13640 or befiradol), exhibits nanomolar affinity at 5-HT1A receptors, and, in Gastrodin to the 5-HT1A receptor agonists listed above, it presents exceptional selectivity and high efficacy at these receptors (Colpaert et al., 2002, Newman-Tancredi et al., 2017). Additionally, it has
11357 records 24/758 page Previous Next First page 上5页 2122232425 下5页 Last page